Did Cyclotron CE Mark Just Shift GE HealthCare's (GEHC) Investment Narrative?

GE HealthCare Technologies recently expanded its PETtrace Solid Target Platform to support Copper-64 production and secured CE Mark approval for its MINItrace Magni cyclotron, increasing its role in PET radioisotope supply and theranostics research infrastructure. This combination of expanded isotope support and certified in house cyclotron production points to GE HealthCare’s push for deeper integration across molecular imaging hardware, radiopharmacy workflow, and emerging...